A polypeptide is a chain of amino acids linked end to end by peptide bonds, which are the covalent connections that form when the carboxyl group of one amino acid reacts with the amino group of the next, releasing a molecule of water. Every protein in your body, from the hemoglobin ferrying oxygen through your blood to the collagen holding your skin together, is built from one or more polypeptide chains. The boundary between “peptide” and “polypeptide” is fuzzy and somewhat arbitrary, but chains shorter than about 20 amino acids are usually called peptides, while longer chains earn the polypeptide label. Once a polypeptide folds into a stable three-dimensional shape and becomes functional, it is commonly called a protein, though the terms overlap in everyday use.
How Cells Build Polypeptide Chains
Your cells manufacture polypeptides on ribosomes, the molecular machines found in every living cell. Inside the ribosome sits a region called the peptidyl transferase center, which catalyzes the actual bond-forming chemistry. It does this by bringing together two molecules of transfer RNA, each carrying an amino acid, and promoting a reaction in which the growing chain is handed from one tRNA to the next while a new peptide bond snaps into place.1PubMed Central. Modulating the activity of the peptidyl transferase center of the ribosome The ribosome does not just passively hold the ingredients. The correct positioning of the two substrates triggers rearrangements of the ribosome’s own structure, creating a chemical environment that stabilizes the reaction and helps shuttle protons around the active site.2PubMed. The mechanism of peptidyl transfer catalysis by the ribosome
After each new peptide bond forms, the ribosome has to reset itself for the next round. Research on the structural dynamics of the peptidyl transferase center suggests that the energy released by forming the new bond is partly recycled to push a key ribosomal component out of the way, clearing space for the next amino acid. It is a kind of mechanical stroke powered by chemistry.3Scientific Reports. Peptidyl transferase center decompaction and structural constraints during early protein elongation on the ribosome This cycle repeats, sometimes hundreds or thousands of times, until the ribosome reaches a stop signal on the messenger RNA and releases the finished polypeptide chain.
From Chain to Shape
A newly made polypeptide is a floppy, linear string. On its own, that string cannot do much. What turns it into a working molecule is folding: the chain coils and bends into specific three-dimensional arrangements driven largely by the chemical properties of its amino acid side chains and by hydrogen bonds forming between the backbone atoms.
The most common local folding patterns are alpha helices, where the chain winds into a tight spiral, and beta sheets, where segments of the chain lie side by side and are held together by hydrogen bonds running perpendicular to the strands. Computational studies of small peptides have shown that, beyond the obvious hydrogen bonds between the carbonyl oxygen and the amide hydrogen of the backbone, additional hydrogen bonds between nitrogen atoms also contribute to the stability of several of these structures, including beta turns and various types of helices.4International Journal of Quantum Chemistry. Hydrogen bonding in peptide secondary structures
On top of these local patterns, the entire chain folds into a compact globular shape (or in some cases an elongated fibrous one), stabilized by a combination of forces. Hydrophobic amino acids tend to cluster in the interior, away from water, while charged and polar residues face outward. Disulfide bonds, which are covalent links between two cysteine residues, can lock parts of the structure in place. In some proteins, this cross-linking only happens after the chain has already collapsed into roughly the right shape. Work on bovine pancreatic trypsin inhibitor demonstrated that its single native disulfide bond forms only after the polypeptide chain has collapsed and the core beta-sheet structure is fully in place.5PubMed Central. Protein folding guides disulfide bond formation In other words, the chain finds its shape first, and the disulfide bond acts like a pin holding the shape together rather than a force that creates it.
Some functional molecules consist of multiple polypeptide chains that assemble together. A designed model protein made of two identical 35-residue alpha-helical polypeptide chains arranged in a coiled-coil structure showed that interchain hydrophobic contacts from leucine residues, combined with an interchain disulfide bond, are what keep the whole assembly stable.6PubMed Central. Synthetic model proteins: contribution of hydrophobic residues and disulfide bonds to protein stability
Fine-Tuning After Assembly
The story does not end once a polypeptide folds. Cells chemically modify many proteins after they are synthesized, a process collectively known as post-translational modification. These modifications include attaching phosphate groups, sugar chains, lipid anchors, or small protein tags like ubiquitin, among many others. By changing a protein’s shape, charge, location within the cell, stability, or ability to interact with other molecules, post-translational modifications ultimately alter what the protein does and how the cell behaves.7PubMed Central. Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications
One particularly well-studied function of these modifications is controlling how long a protein lasts before the cell destroys it. Modifications can reversibly change a protein’s physical and chemical properties, and in many cases these changes create or block docking sites for the cellular machinery that tags proteins for destruction.8Nature Communications. Control of protein stability by post-translational modifications This gives cells a rapid, reversible way to dial the concentration of any given protein up or down without having to make new copies or stop production at the genetic level.
Structural Roles in the Body
Collagen is the most abundant protein in your body, and it is a good illustration of how polypeptide structure dictates function. Collagen’s basic unit is a triple helix: three left-handed polypeptide helices wind around each other in a right-handed rope.9PubMed Central. Collagen structure and stability This arrangement gives collagen remarkable tensile strength, which is why it shows up in tendons, cartilage, skin, and bone. Beyond pure scaffolding, collagen influences cell signaling, cell movement, and cell differentiation, so it does more than simply hold things in place.10PubMed. Mechanics and structural stability of the collagen triple helix
Atomistic modeling of individual collagen molecules has predicted their persistence length at about 23.4 nanometers, close to what experiments measure, and has shown that the way bonds stretch and break at large strains is critical for understanding how collagen-rich tissues handle extreme forces.11Journal of Materials Research. Atomistic and continuum modeling of mechanical properties of collagen: Elasticity, fracture, and self-assembly This kind of detailed structural understanding is now guiding the design of artificial collagen-like materials for wound repair and tissue engineering.
Signaling and Hormones
Many of the chemical messengers that coordinate activity between distant cells are short polypeptides. Insulin, oxytocin, and growth hormone are all peptide hormones. They work by binding to receptors on the surface of target cells, which triggers a cascade of reactions inside the cell that ultimately changes its metabolism, growth, or behavior.12PubMed. Cellular signalling: Peptide hormones and growth factors Because peptide hormones are broken down quickly by enzymes in the blood, their signals tend to be fast and short-lived compared to steroid hormones, which linger longer. This rapid turnover makes them well suited for moment-to-moment regulation of things like blood sugar or uterine contractions.
Immune Defense
Your immune system relies heavily on small polypeptides called antimicrobial peptides, or AMPs. These molecules are rapidly produced at surfaces like the skin and the lining of the gut, where they serve as a first line of defense against bacteria, viruses, fungi, and parasites.13Trends in Immunology. Antimicrobial peptides: multifunctional molecules of immune defense Most carry a positive charge, which attracts them to the negatively charged membranes of bacteria. Their hydrophobic portions then insert into those membranes, disrupting them and causing the bacterial cell to leak and die.14Frontiers in Immunology. Antimicrobial peptides´ immune modulation role in intracellular bacterial infection
But killing microbes directly is only part of what AMPs do. They also recruit white blood cells to sites of infection, stimulate the release of signaling molecules called cytokines, neutralize bacterial toxins, and help bridge the fast-acting innate immune system with the slower, more targeted adaptive immune system.14Frontiers in Immunology. Antimicrobial peptides´ immune modulation role in intracellular bacterial infection Some, like bactericidal/permeability-increasing protein found in neutrophils, can both punch holes in bacterial membranes and coat the bacteria to make them easier for immune cells to engulf.15PubMed. Antimicrobial peptides: the ancient arm of the human immune system
When Folding Goes Wrong
Because a polypeptide’s function depends on its shape, misfolding can have devastating consequences. In several neurodegenerative diseases, polypeptides that normally fold correctly instead adopt an abnormal, sticky conformation rich in beta-sheet structure. These misfolded molecules aggregate first into small clusters called oligomers, then into larger fibrils known as amyloid. The process is self-reinforcing: each misfolded molecule serves as a template that coerces its neighbors into the same wrong shape.16Nature Reviews Molecular Cell Biology. Mechanisms and pathology of protein misfolding and aggregation
The visible clumps of amyloid that accumulate in the brain were long assumed to be the primary culprits, but research increasingly points to the smaller, earlier-stage oligomers as the more toxic species. The large aggregates may actually represent an end stage of the process, and there is only partial overlap between the cells that accumulate visible deposits and the cells that die.17Nature Medicine. Protein aggregation and neurodegenerative disease The underlying cascade follows a seeding-nucleation model, in which a small seed of misfolded protein forms first and then rapidly recruits more molecules, driven by hydrogen bonding and hydrophobic interactions between the exposed beta-sheet edges.18PubMed Central. Misfolding and aggregation in neurodegenerative diseases: protein quality control machinery as potential therapeutic clearance pathways
Polypeptides Without a Fixed Shape
Not every polypeptide needs to fold into a stable structure to do its job. A substantial fraction of the proteins involved in cellular signaling are intrinsically disordered, meaning they remain flexible and lack a fixed three-dimensional shape under normal conditions. This flexibility is a feature, not a defect. It allows a single polypeptide to interact with multiple different partners and produce different outcomes depending on the context.19PubMed Central. Intrinsically disordered proteins in cellular signalling and regulation Disordered proteins are also key players in the assembly of membrane-less organelles inside cells, like the liquid-like droplets in the nucleus that concentrate specific molecules for gene regulation. The realization that disorder can be functional has reshaped how researchers think about the relationship between structure and activity.
Peptides Made Without Ribosomes
Ribosomes are not the only game in town for making peptides. Bacteria and fungi produce a wide variety of biologically active peptides using a completely different system: nonribosomal peptide synthetases, or NRPSs. These are giant multimodular enzymes that assemble peptides one amino acid at a time on an assembly line, but they can incorporate amino acids that ribosomes cannot use, including unusual and modified building blocks that give the resulting molecules distinctive chemical properties.20PubMed. Nonribosomal Peptide Synthesis-Principles and Prospects
The pharmaceutical importance of this pathway is hard to overstate. More than 20 marketed drugs are nonribosomal peptides, including the antibiotic penicillin, the last-resort antibiotic vancomycin, the antitumor agent bleomycin, and the immunosuppressant cyclosporine.20PubMed. Nonribosomal Peptide Synthesis-Principles and Prospects Researchers are now using synthetic biology to re-engineer these enzyme assembly lines, hoping to generate new peptide structures that could serve as next-generation antimicrobials at a time when antibiotic resistance is a growing problem.21PubMed Central. Nonribosomal peptide synthetases and their biotechnological potential in Penicillium rubens
Building Peptides in the Lab
Chemists can also synthesize polypeptides from scratch, without any biological machinery at all. The dominant method is solid-phase peptide synthesis, in which amino acids are added one at a time to a growing chain that is anchored to a solid bead. The chain grows from the C-terminus to the N-terminus, the reverse of how ribosomes build it. Each step involves removing a protective chemical group from the end of the chain, coupling the next amino acid on, and washing away unreacted material. The Fmoc/tBu approach is now the most widely used version of this method.22PubMed. Methods and protocols of modern solid phase Peptide synthesis
Solid-phase synthesis is what makes peptide-based drugs possible, but getting a peptide to work as a medicine is a challenge. Peptides are quickly chopped up by enzymes in the gut and bloodstream, and they have trouble crossing cell membranes. To address this, medicinal chemists use strategies like cyclizing the chain into a ring, swapping in nonstandard amino acids that resist digestion, attaching polyethylene glycol chains to slow clearance, or grafting on fatty acid tails that let the peptide hitch a ride on blood proteins.23Journal of Medicinal Chemistry. Overcoming Challenges in the Metabolism of Peptide Therapeutics: Strategies and Case Studies for Clinical Success These modifications have turned peptides from laboratory curiosities into a growing class of therapeutics, with semaglutide (the active ingredient in Ozempic and Wegovy) being perhaps the most prominent recent example.
Beyond medicine, peptides are being developed as building blocks for materials science. Short peptides can self-assemble into nanofibers that further intertwine into hydrogels, three-dimensional water-rich networks with potential uses in wound healing, tissue engineering, and drug delivery.24ACS Materials Letters. Preparation and Properties of Self-Assembling Peptide Hydrogels and Their Application in Biomedicine
Venom Peptides as a Source of Drug Leads
Some of nature’s most precisely engineered polypeptides come from cone snails, a group of predatory marine molluscs that hunt worms, other snails, and even fish using venom loaded with small, tightly folded peptide toxins called conotoxins. The vast majority of these peptides selectively target specific types of ion channels, the tiny pores in cell membranes that control the flow of charged atoms.25PubMed. Conus venoms: a rich source of novel ion channel-targeted peptides Because each conotoxin tends to lock onto one channel subtype and ignore everything else, these venoms are both a goldmine for neuroscience research (they let scientists turn individual channel types on and off) and a rich source of drug leads. One cone snail peptide, ziconotide, is already approved as a painkiller for severe chronic pain, and dozens more are under investigation.
Each cone snail species can produce a hundred or more distinct conotoxins, and with hundreds of species in the genus, the total library of venom peptides is enormous. That level of chemical diversity, all encoded in short polypeptide chains, underscores just how much functional variety can be packed into a relatively small molecular framework.
Peptides and the Origin of Life
One of the enduring puzzles in origin-of-life research is how the first polypeptides formed on a planet that had no ribosomes, no enzymes, and no genetic code. Linking amino acids into peptide bonds in water is thermodynamically unfavorable because the reaction releases water, and in an aqueous environment the equilibrium favors breaking those bonds rather than forming them.26PubMed Central. Amino acid analogues provide multiple plausible pathways to prebiotic peptides
Recent experiments have found creative ways around this barrier. A study simulating lightning striking the ocean surface used bubble bursting combined with arc plasma under ambient conditions and demonstrated that dipeptides could form from six different amino acids, with conversion rates ranging from about 3% to 26%. When the researchers used a mixture of all 20 standard amino acids, they generated 102 different dipeptides and even some biologically relevant tripeptides.27PubMed. Prebiotic Formation of Peptides Through Bubbling and Arc Plasma Other researchers are exploring whether amino acid analogues, molecules chemically similar to standard amino acids but with slightly different properties, might have served as more reactive building blocks on early Earth, bypassing the thermodynamic bottleneck and kicking off the chemical evolution that eventually gave rise to modern proteins.26PubMed Central. Amino acid analogues provide multiple plausible pathways to prebiotic peptides The gap between a handful of short peptides forming by accident and a self-replicating system is still vast, but these experiments show that the first step, making peptide bonds without biology, is more achievable than it once seemed.